"Pharmaceutical headlines" health care directory to adjust the focus! 7 big ticket companies how to make the most of it.

(2020/08/05) Understand the 2020 health care directory adjustment focus! 7 big ticket enterprises how to make the best use of; the state directive to clean up all hospital rebates covert visit group departure; JD Health, Hualan biological ... 47 Chinese medical unicorn rankings open ... (Click on the title, you can get the original text) "Pharmaceutical 1st time" Bayer in the first half of the year to achieve revenue of 22.9 billion euros in China business affected by the volume of procurement! Despite the COVID-19 pandemic and related uncertainties, Bayer's business delivered solid results in the first half of the year: Group sales of EUR 22,899 million (up 8.4 per cent), including: Cropscience EUR 11,636 million (up 4.6 per cent), pharmaceuticals EUR 8,538 million (down 2.5 per cent), consumer health business EUR 2,599 million (up 5.7 per cent).
core EPS was 4.26 euros, up 8.1 percent.
headline: Eylea's sales performance remains strong.
( 8 o'clock health ) An outbreak A group of people who have lost their sense of smell Some patients with new coronary light disease in the rehabilitation process, some people smell failure, some people have vision loss, there are complex symptoms, they do not know whether these symptoms can return to normal.
: Bless them and get better and better.
The E Drug Manager: JD.com Health, Hualan Bio... On August 4th, the Hurun Research Institute of 47 Chinese medical unicorn rankings released the "Suzhou High-speed Zone 2020 Hurun Global Unicorn List".
list of unseeded companies valued at more than $1 billion as of March 31, 2020, when they were established in 2000.
a total of 47 unicorn companies involved in the field of health care, divided into biotechnology and health technology two sub-sectors.
: Someone's surging and someone's leaving.
" hepatitis "drug king" market value of more than 120 billion! Taking over the name of Chinese medicine to Tongrentang recently, the news that the film to the Dragon's Ernst Pharmaceutical Industry to invest in holding the news has attracted the attention of the industry, has been the title of the hepatitis "drug king" to dominate the high retail market, although the price of raw materials on the product round to increase prices, still can not stop its performance all the way up.
the outbreak, the company bucked the trend, with a half-year net profit of 860 million yuan, the latest market value has exceeded 120 billion yuan, up more than 87% so far this year.
the headlines: the performance of the film is not down and up.
insight database to understand the 2020 health care directory adjustment focus! 7 ticket enterprises how to make the best use of their hopes, "2020 National Health Insurance Drug Catalog Adjustment Work Programme (Draft for Comments)" public consultation was finally released on August 3, according to the last National Health Insurance Administration issued the health insurance drug catalog adjustment work program has been 17 and a half months, this is also the "Basic Health Insurance Drug Administration Interim Measures" after the official release of a major landing initiative, health insurance catalog dynamic adjustment, in principle, once a year.
: Drugs will eventually return to their roots.
"Seba Blue Equipment" State Directive to rectify all hospital rebates a few days before the departure of the secret visit group, the National Health And Health Commission issued the "2020 medical industry style construction work special action plan", the focus of this program is to standardize the behavior of medical institutions and their practitioners, issued to the provinces, autonomous regions, municipalities directly under the Central Government and Xinjiang Production and Construction Corps Health and Health Committee, began to organize the implementation.
: Strict regulation is not an accelerator for industry progress.
.